Production (Stage)
Burning Rock Biotech Limited
BNR
$3.56
$0.17415.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | 37.19% | 37.19% |
| Total Depreciation and Amortization | -- | -- | -- | 7.14% | 7.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -42.75% | -42.75% |
| Total Other Non-Cash Items | -- | -- | -- | -13.95% | -13.95% |
| Change in Net Operating Assets | -- | -- | -- | -359.99% | -359.99% |
| Cash from Operations | -- | -- | -- | 58.86% | 58.86% |
| Capital Expenditure | -- | -- | -- | 88.65% | 88.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -96.59% | -96.59% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -99.59% | -99.59% |
| Cash from Investing | -- | -- | -- | -363.02% | -363.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 90.29% | 90.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -414.24% | -414.24% |
| Cash from Financing | -- | -- | -- | 45.37% | 45.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -75.65% | -75.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 53.39% | 53.39% |